speb/financial-data huggingface dataset:
CD2.AX income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -2441739.00
CD2.AX income_statement (annual, 2023-03-31) — Net Interest Income: 137809.00
CD2.AX balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 83379498.00
CD2.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 6065654.00
CD2.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 6065654.00
CD2.AX income_statement (annual, 2023-03-31) — Normalized Income: -2441739.00
CD2.AX income_statement (annual, 2023-03-31) — Operating Revenue: 358833.00
CD2.AX balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 52479086.00
CD2.AX income_statement (annual, 2023-03-31) — Other Non Interest Expense: 291549.00
CD2.AX income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: -1607346.00
CD2.AX balance_sheet (annual, 2023-03-31) — Other Payable: 1721.00
CD2.AX balance_sheet (annual, 2023-03-31) — Other Receivables: 22577.00
CD2.AX balance_sheet (annual, 2023-03-31) — Payables: 179154.00
CD2.AX balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 179154.00
CD2.AX income_statement (annual, 2023-03-31) — Pretax Income: -2375132.00
CD2.AX income_statement (annual, 2023-03-31) — Professional Expense And Contract Services Expense: 835070.00
CD2.AX balance_sheet (annual, 2023-03-31) — Receivables: 31893.00
CD2.AX cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -1025706.00
CD2.AX balance_sheet (annual, 2023-03-31) — Retained Earnings: 487930.00
CD2.AX balance_sheet (annual, 2023-03-31) — Share Issued: 52479086.00
CD2.AX balance_sheet (annual, 2023-03-31) — Stockholders Equity: 83379498.00
CD2.AX balance_sheet (annual, 2023-03-31) — Tangible Book Value: 83379498.00
CD2.AX income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
CD2.AX income_statement (annual, 2023-03-31) — Tax Provision: 66607.00
CD2.AX income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
CD2.AX balance_sheet (annual, 2023-03-31) — Total Assets: 90927997.00
CD2.AX balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 83379498.00
CD2.AX balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 7548499.00
CD2.AX income_statement (annual, 2024-03-31) — +Total Revenue: 145740.00
CD2.AX balance_sheet (annual, 2024-03-31) — Accounts Payable: 134250.00
CD2.AX balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3810.00
CD2.AX income_statement (annual, 2024-03-31) — Basic Average Shares: 52479086.00
CD2.AX income_statement (annual, 2024-03-31) — Basic EPS: 0.20
CD2.AX cash_flow (annual, 2024-03-31) — Beginning Cash Position: 10328531.00
CD2.AX balance_sheet (annual, 2024-03-31) — Capital Stock: 82891568.00
CD2.AX balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 10201733.00
CD2.AX balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 10201733.00
CD2.AX cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -12857378.00
CD2.AX balance_sheet (annual, 2024-03-31) — Cash Financial: 10201733.00
CD2.AX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: -12857378.00
CD2.AX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: 13468964.00
CD2.AX cash_flow (annual, 2024-03-31) — Cash Flowsfromusedin Operating Activities Direct: -993817.00
CD2.AX cash_flow (annual, 2024-03-31) — Changes In Cash: -382231.00
CD2.AX cash_flow (annual, 2024-03-31) — Classesof Cash Payments: -1104532.00
CD2.AX cash_flow (annual, 2024-03-31) — Classesof Cash Receiptsfrom Operating Activities: 110715.00
CD2.AX balance_sheet (annual, 2024-03-31) — Common Stock: 82891568.00
CD2.AX cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -12857378.00
CD2.AX balance_sheet (annual, 2024-03-31) — Common Stock Equity: 80994865.00
CD2.AX income_statement (annual, 2024-03-31) — Diluted Average Shares: 52479086.00
CD2.AX income_statement (annual, 2024-03-31) — Diluted EPS: 0.20
CD2.AX cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 13468964.00
CD2.AX cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 255433.00
CD2.AX cash_flow (annual, 2024-03-31) — End Cash Position: 10201733.00
CD2.AX cash_flow (annual, 2024-03-31) — Financing Cash Flow: -12857378.00
CD2.AX cash_flow (annual, 2024-03-31) — Free Cash Flow: -993817.00
CD2.AX balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3810.00
CD2.AX cash_flow (annual, 2024-03-31) — Income Tax Paid Supplemental Data: 253534.00
CD2.AX income_statement (annual, 2024-03-31) — Interest Income: 105209.00
CD2.AX cash_flow (annual, 2024-03-31) — Investing Cash Flow: 13468964.00
CD2.AX balance_sheet (annual, 2024-03-31) — Investments And Advances: 76877263.00
CD2.AX balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 76877263.00
CD2.AX income_statement (annual, 2024-03-31) — Net Income: 10472745.00
CD2.AX income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 10472745.00
CD2.AX income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 10472745.00
CD2.AX income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 10472745.00
CD2.AX income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 10472745.00
CD2.AX income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 10472745.00
CD2.AX income_statement (annual, 2024-03-31) — Net Interest Income: 105209.00
CD2.AX balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 80994865.00
CD2.AX balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 6263631.00
CD2.AX balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 6263631.00
CD2.AX income_statement (annual, 2024-03-31) — Normalized Income: 10472745.00
CD2.AX income_statement (annual, 2024-03-31) — Operating Revenue: 145740.00
CD2.AX balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 52479086.00
CD2.AX income_statement (annual, 2024-03-31) — Other Non Interest Expense: 29711.00
CD2.AX income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 13034774.00
CD2.AX balance_sheet (annual, 2024-03-31) — Other Payable: 1695.00
CD2.AX balance_sheet (annual, 2024-03-31) — Other Receivables: 20461.00
CD2.AX balance_sheet (annual, 2024-03-31) — Payables: 135945.00
CD2.AX balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 135945.00
CD2.AX income_statement (annual, 2024-03-31) — Pretax Income: 12456136.00
CD2.AX income_statement (annual, 2024-03-31) — Professional Expense And Contract Services Expense: 694667.00
CD2.AX balance_sheet (annual, 2024-03-31) — Receivables: 24271.00
CD2.AX balance_sheet (annual, 2024-03-31) — Retained Earnings: -1896703.00
CD2.AX balance_sheet (annual, 2024-03-31) — Share Issued: 52479086.00
CD2.AX balance_sheet (annual, 2024-03-31) — Stockholders Equity: 80994865.00
CD2.AX balance_sheet (annual, 2024-03-31) — Tangible Book Value: 80994865.00
CD2.AX income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
CD2.AX income_statement (annual, 2024-03-31) — Tax Provision: 1983391.00
CD2.AX income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.16
CD2.AX balance_sheet (annual, 2024-03-31) — Total Assets: 87394441.00
CD2.AX balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 80994865.00
CD2.AX balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 6399576.00
CD2.AX income_statement (quarterly, 2024-09-30) — +Total Revenue: -7445564.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 109306.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 46615.00
CD2.AX income_statement (quarterly, 2024-09-30) — Basic Average Shares: 52479086.00
CD2.AX income_statement (quarterly, 2024-09-30) — Basic EPS: -0.16
CD2.AX cash_flow (quarterly, 2024-09-30) — Beginning Cash Position: 10201733.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Capital Stock: 82891568.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 5424058.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Federal Funds Sold: 5424058.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: -3673536.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Cash Financial: 5424058.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: -3673536.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: 1281074.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Cash Flowsfromusedin Operating Activities Direct: -1923327.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Changes In Cash: -4315789.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Classesof Cash Payments: -1948904.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Classesof Cash Receiptsfrom Operating Activities: 25577.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Common Stock: 82891568.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -3673536.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 68981160.00
CD2.AX income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 52479086.00
CD2.AX income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.16
CD2.AX cash_flow (quarterly, 2024-09-30) — Effect Of Exchange Rate Changes: -461886.00
CD2.AX cash_flow (quarterly, 2024-09-30) — End Cash Position: 5424058.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: -3673536.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Free Cash Flow: -1923327.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 46615.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 1561575.00
CD2.AX income_statement (quarterly, 2024-09-30) — Interest Income: 23849.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: 1281074.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 68106287.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 68106287.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 5532109.00
CD2.AX income_statement (quarterly, 2024-09-30) — Net Income: -8340169.00
CD2.AX income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: -8340169.00
CD2.AX income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: -8340169.00
CD2.AX income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -8340169.00
CD2.AX income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -8340169.00
CD2.AX income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: -8340169.00
CD2.AX income_statement (quarterly, 2024-09-30) — Net Interest Income: 23849.00
CD2.AX cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 1281074.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 68981160.00
CD2.AX income_statement (quarterly, 2024-09-30) — Normalized Income: -8340169.00
CD2.AX income_statement (quarterly, 2024-09-30) — Operating Revenue: -7445564.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 52479086.00
CD2.AX income_statement (quarterly, 2024-09-30) — Other Non Interest Expense: 3801.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Payables: 109306.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Payables And Accrued Expenses: 109306.00
CD2.AX income_statement (quarterly, 2024-09-30) — Pretax Income: -7740317.00
CD2.AX income_statement (quarterly, 2024-09-30) — Professional Expense And Contract Services Expense: 290952.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Receivables: 46615.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Retained Earnings: -13910408.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Share Issued: 52479086.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 68981160.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 68981160.00
CD2.AX income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
CD2.AX income_statement (quarterly, 2024-09-30) — Tax Provision: 599852.00
CD2.AX income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.30
CD2.AX balance_sheet (quarterly, 2024-09-30) — Total Assets: 74622575.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 68981160.00
CD2.AX balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 5641415.00
CD2.AX income_statement (annual, 2025-03-31) — +Total Revenue: 279061.00
CD2.AX balance_sheet (annual, 2025-03-31) — Accounts Payable: 124892.00
CD2.AX balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2580.00
CD2.AX income_statement (annual, 2025-03-31) — Basic Average Shares: 52479086.00
CD2.AX income_statement (annual, 2025-03-31) — Basic EPS: 0.00
CD2.AX cash_flow (annual, 2025-03-31) — Beginning Cash Position: 10201733.00
CD2.AX balance_sheet (annual, 2025-03-31) — Capital Stock: 82891568.00
CD2.AX balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 4873981.00
CD2.AX balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 4873981.00
CD2.AX cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -8396654.00
CD2.AX balance_sheet (annual, 2025-03-31) — Cash Financial: 4873981.00
CD2.AX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: -8396654.00
CD2.AX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: 5288430.00
CD2.AX cash_flow (annual, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: -2248555.00
CD2.AX cash_flow (annual, 2025-03-31) — Changes In Cash: -5356779.00
CD2.AX cash_flow (annual, 2025-03-31) — Classesof Cash Payments: -2288205.00
CD2.AX cash_flow (annual, 2025-03-31) — Classesof Cash Receiptsfrom Operating Activities: 39650.00
CD2.AX balance_sheet (annual, 2025-03-31) — Common Stock: 82891568.00
CD2.AX cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -8396654.00
CD2.AX balance_sheet (annual, 2025-03-31) — Common Stock Equity: 72805975.00
CD2.AX income_statement (annual, 2025-03-31) — Diluted Average Shares: 52479086.00
CD2.AX income_statement (annual, 2025-03-31) — Diluted EPS: 0.00
CD2.AX cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 5288430.00
CD2.AX cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 29027.00
CD2.AX cash_flow (annual, 2025-03-31) — End Cash Position: 4873981.00
CD2.AX cash_flow (annual, 2025-03-31) — Financing Cash Flow: -8396654.00
CD2.AX cash_flow (annual, 2025-03-31) — Free Cash Flow: -2248555.00
CD2.AX balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2580.00
CD2.AX cash_flow (annual, 2025-03-31) — Income Tax Paid Supplemental Data: 1561575.00
CD2.AX income_statement (annual, 2025-03-31) — Interest Income: 38424.00
CD2.AX cash_flow (annual, 2025-03-31) — Investing Cash Flow: 5288430.00
CD2.AX balance_sheet (annual, 2025-03-31) — Investments And Advances: 73407327.00
CD2.AX balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 73407327.00
CD2.AX income_statement (annual, 2025-03-31) — Net Income: 207764.00
CD2.AX income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 207764.00
CD2.AX income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 207764.00
CD2.AX income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 207764.00
CD2.AX income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 207764.00
CD2.AX income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 207764.00
CD2.AX income_statement (annual, 2025-03-31) — Net Interest Income: 38424.00
CD2.AX balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 72805975.00
CD2.AX balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 6221058.00
CD2.AX balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 6221058.00
CD2.AX income_statement (annual, 2025-03-31) — Normalized Income: 207764.00
CD2.AX income_statement (annual, 2025-03-31) — Operating Revenue: 279061.00
CD2.AX balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 52479086.00
CD2.AX income_statement (annual, 2025-03-31) — Other Non Interest Expense: 5942.00
CD2.AX income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 3426296.00
CD2.AX balance_sheet (annual, 2025-03-31) — Other Payable: 1645.00
CD2.AX balance_sheet (annual, 2025-03-31) — Other Receivables: 18679.00
CD2.AX balance_sheet (annual, 2025-03-31) — Payables: 126537.00
CD2.AX balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 126537.00
CD2.AX income_statement (annual, 2025-03-31) — Pretax Income: 3063320.00
CD2.AX income_statement (annual, 2025-03-31) — Professional Expense And Contract Services Expense: 636095.00
CD2.AX balance_sheet (annual, 2025-03-31) — Receivables: 21259.00
CD2.AX balance_sheet (annual, 2025-03-31) — Retained Earnings: -10085593.00
CD2.AX balance_sheet (annual, 2025-03-31) — Share Issued: 52479086.00
CD2.AX balance_sheet (annual, 2025-03-31) — Stockholders Equity: 72805975.00
CD2.AX balance_sheet (annual, 2025-03-31) — Tangible Book Value: 72805975.00
CD2.AX income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CD2.AX income_statement (annual, 2025-03-31) — Tax Provision: 2855556.00
CD2.AX income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
CD2.AX balance_sheet (annual, 2025-03-31) — Total Assets: 79153570.00
CD2.AX balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 72805975.00
CD2.AX balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 6347595.00
CD2.AX income_statement (annual, 2026-03-31) — +Total Revenue: -1386188.00
CD2.AX cash_flow (annual, 2026-03-31) — Beginning Cash Position: 4873981.00
CD2.AX balance_sheet (annual, 2026-03-31) — Capital Stock: 82891568.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 82891568.00
CD2.AX balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 6450406.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 6450406.00
CD2.AX balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 6450406.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 6450406.00
CD2.AX cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -29388288.00
CD2.AX balance_sheet (annual, 2026-03-31) — Cash Financial: 6450406.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Cash Financial: 6450406.00
CD2.AX cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -29388288.00
CD2.AX cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: 33440374.00
CD2.AX cash_flow (annual, 2026-03-31) — Cash Flowsfromusedin Operating Activities Direct: -557112.00
CD2.AX cash_flow (annual, 2026-03-31) — Changes In Cash: 3494974.00
CD2.AX cash_flow (annual, 2026-03-31) — Classesof Cash Payments: -659976.00
CD2.AX cash_flow (annual, 2026-03-31) — Classesof Cash Receiptsfrom Operating Activities: 102864.00
CD2.AX balance_sheet (annual, 2026-03-31) — Common Stock: 82891568.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Common Stock: 82891568.00
CD2.AX cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -29388288.00
CD2.AX balance_sheet (annual, 2026-03-31) — Common Stock Equity: 32915826.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 32915826.00
CD2.AX balance_sheet (annual, 2026-03-31) — Current Deferred Liabilities: 3472864.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 3472864.00
CD2.AX balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 3472864.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 3472864.00
CD2.AX cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 33440374.00
CD2.AX cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -1918549.00
CD2.AX cash_flow (annual, 2026-03-31) — End Cash Position: 6450406.00
CD2.AX cash_flow (annual, 2026-03-31) — Financing Cash Flow: -29388288.00
CD2.AX cash_flow (annual, 2026-03-31) — Free Cash Flow: -557112.00
CD2.AX income_statement (annual, 2026-03-31) — Interest Income: 102722.00
CD2.AX cash_flow (annual, 2026-03-31) — Investing Cash Flow: 33440374.00
CD2.AX balance_sheet (annual, 2026-03-31) — Investments And Advances: 31197251.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 31197251.00
CD2.AX balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 31197251.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 31197251.00
CD2.AX income_statement (annual, 2026-03-31) — Net Income: -10501861.00
CD2.AX income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -10501861.00
CD2.AX income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -10501861.00
CD2.AX income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -10501861.00
CD2.AX income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -10501861.00
CD2.AX income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -10501861.00
CD2.AX income_statement (annual, 2026-03-31) — Net Interest Income: 102722.00
CD2.AX balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 32915826.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 32915826.00
CD2.AX balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 1153558.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1153558.00
CD2.AX balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1153558.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1153558.00
CD2.AX income_statement (annual, 2026-03-31) — Normalized Income: -10501861.00
CD2.AX income_statement (annual, 2026-03-31) — Operating Revenue: -1386188.00
CD2.AX balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 52479086.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 52479086.00
CD2.AX income_statement (annual, 2026-03-31) — Other Non Interest Expense: 5297.00
CD2.AX income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: -7843021.00
CD2.AX balance_sheet (annual, 2026-03-31) — Other Payable: 125574.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Other Payable: 125574.00
CD2.AX balance_sheet (annual, 2026-03-31) — Other Receivables: 20165.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 20165.00
CD2.AX balance_sheet (annual, 2026-03-31) — Payables: 125574.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Payables: 125574.00
CD2.AX balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 125574.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 125574.00
CD2.AX income_statement (annual, 2026-03-31) — Pretax Income: -9813982.00
CD2.AX income_statement (annual, 2026-03-31) — Professional Expense And Contract Services Expense: 579476.00
CD2.AX balance_sheet (annual, 2026-03-31) — Receivables: 20165.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Receivables: 20165.00
CD2.AX balance_sheet (annual, 2026-03-31) — Retained Earnings: -49975742.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -49975742.00
CD2.AX balance_sheet (annual, 2026-03-31) — Share Issued: 52479086.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Share Issued: 52479086.00
CD2.AX balance_sheet (annual, 2026-03-31) — Stockholders Equity: 32915826.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 32915826.00
CD2.AX balance_sheet (annual, 2026-03-31) — Tangible Book Value: 32915826.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 32915826.00
CD2.AX income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CD2.AX income_statement (annual, 2026-03-31) — Tax Provision: 687879.00
CD2.AX income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
CD2.AX balance_sheet (annual, 2026-03-31) — Total Assets: 37667822.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Total Assets: 37667822.00
CD2.AX balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 32915826.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 32915826.00
CD2.AX balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 4751996.00
CD2.AX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4751996.00
CD3.AX income_statement (annual, 2022-03-31) — +Total Revenue: -241846.00
CD3.AX balance_sheet (annual, 2022-03-31) — Accounts Payable: 34996.00
CD3.AX balance_sheet (annual, 2022-03-31) — Accounts Receivable: 19469.00
CD3.AX income_statement (annual, 2022-03-31) — Basic Average Shares: 72028420.00
CD3.AX income_statement (annual, 2022-03-31) — Basic EPS: 0.81
CD3.AX cash_flow (annual, 2022-03-31) — Beginning Cash Position: 18030336.00
CD3.AX balance_sheet (annual, 2022-03-31) — Capital Stock: 109672616.00
CD3.AX balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 23710544.00
CD3.AX balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 23710544.00
CD3.AX cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -47178618.00
CD3.AX balance_sheet (annual, 2022-03-31) — Cash Financial: 23710544.00
CD3.AX cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: -47178618.00
CD3.AX cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: 53531269.00
CD3.AX cash_flow (annual, 2022-03-31) — Cash Flowsfromusedin Operating Activities Direct: -942794.00
CD3.AX cash_flow (annual, 2022-03-31) — Changes In Cash: 5409857.00
CD3.AX cash_flow (annual, 2022-03-31) — Classesof Cash Payments: -951666.00
CD3.AX cash_flow (annual, 2022-03-31) — Classesof Cash Receiptsfrom Operating Activities: 8872.00
CD3.AX balance_sheet (annual, 2022-03-31) — Common Stock: 109672616.00
CD3.AX cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -47178618.00
CD3.AX balance_sheet (annual, 2022-03-31) — Common Stock Equity: 166307965.00
CD3.AX balance_sheet (annual, 2022-03-31) — Current Deferred Liabilities: 1435316.00
CD3.AX balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 1435316.00
CD3.AX income_statement (annual, 2022-03-31) — Diluted Average Shares: 72028420.00
CD3.AX income_statement (annual, 2022-03-31) — Diluted EPS: 0.81
CD3.AX cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 53531269.00
CD3.AX cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 270351.00
CD3.AX cash_flow (annual, 2022-03-31) — End Cash Position: 23710544.00
CD3.AX cash_flow (annual, 2022-03-31) — Financing Cash Flow: -47178618.00
CD3.AX cash_flow (annual, 2022-03-31) — Free Cash Flow: -942794.00
CD3.AX balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 19469.00
CD3.AX cash_flow (annual, 2022-03-31) — Income Tax Paid Supplemental Data: -30165.00
CD3.AX income_statement (annual, 2022-03-31) — Interest Income: 9284.00
CD3.AX cash_flow (annual, 2022-03-31) — Investing Cash Flow: 53531269.00
CD3.AX balance_sheet (annual, 2022-03-31) — Investments And Advances: 148721726.00
CD3.AX balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 148721726.00
CD3.AX income_statement (annual, 2022-03-31) — Net Income: 58696010.00
CD3.AX income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 58696010.00
CD3.AX income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 58696010.00
CD3.AX income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 58696010.00
CD3.AX income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 58696010.00
CD3.AX income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 58696010.00
CD3.AX income_statement (annual, 2022-03-31) — Net Interest Income: 9284.00
CD3.AX balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 166307965.00
CD3.AX balance_sheet (annual, 2022-03-31) — Non Current Deferred Liabilities: 4450821.00
CD3.AX balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 4450821.00
CD3.AX income_statement (annual, 2022-03-31) — Normalized Income: 58696010.00
CD3.AX income_statement (annual, 2022-03-31) — Operating Revenue: -241846.00
CD3.AX balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 72028420.00
CD3.AX income_statement (annual, 2022-03-31) — Other Non Interest Expense: 4939.00
CD3.AX income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 64255602.00
CD3.AX balance_sheet (annual, 2022-03-31) — Other Payable: 234306.00
CD3.AX balance_sheet (annual, 2022-03-31) — Payables: 269302.00
CD3.AX balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 269302.00
CD3.AX income_statement (annual, 2022-03-31) — Pretax Income: 63032319.00
CD3.AX income_statement (annual, 2022-03-31) — Professional Expense And Contract Services Expense: 976498.00
CD3.AX balance_sheet (annual, 2022-03-31) — Receivables: 19469.00
CD3.AX balance_sheet (annual, 2022-03-31) — Retained Earnings: 56635349.00
CD3.AX balance_sheet (annual, 2022-03-31) — Share Issued: 72028420.00
CD3.AX balance_sheet (annual, 2022-03-31) — Stockholders Equity: 166307965.00
CD3.AX balance_sheet (annual, 2022-03-31) — Tangible Book Value: 166307965.00
CD3.AX income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
CD3.AX income_statement (annual, 2022-03-31) — Tax Provision: 4336309.00
CD3.AX income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.07
CD3.AX balance_sheet (annual, 2022-03-31) — Total Assets: 172463404.00
CD3.AX balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 166307965.00
CD3.AX balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 6155439.00
CD3.AX income_statement (annual, 2023-03-31) — +Total Revenue: 233026.90
CD3.AX balance_sheet (annual, 2023-03-31) — Accounts Payable: 1386.00
CD3.AX balance_sheet (annual, 2023-03-31) — Accounts Receivable: 29160.00
CD3.AX income_statement (annual, 2023-03-31) — Basic Average Shares: 72028420.00
CD3.AX income_statement (annual, 2023-03-31) — Basic EPS: 0.41
CD3.AX cash_flow (annual, 2023-03-31) — Beginning Cash Position: 23710544.00
CD3.AX balance_sheet (annual, 2023-03-31) — Capital Stock: 109672616.00
CD3.AX balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 29291029.00
CD3.AX balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 29291029.00
CD3.AX cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -40407943.00
CD3.AX balance_sheet (annual, 2023-03-31) — Cash Financial: 29291029.00
CD3.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: -40407943.00
CD3.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: 45108780.00
CD3.AX cash_flow (annual, 2023-03-31) — Cash Flowsfromusedin Operating Activities Direct: -1336307.00
CD3.AX cash_flow (annual, 2023-03-31) — Changes In Cash: 3364530.00
CD3.AX cash_flow (annual, 2023-03-31) — Classesof Cash Payments: -1519968.00
CD3.AX cash_flow (annual, 2023-03-31) — Classesof Cash Receiptsfrom Operating Activities: 183661.00
CD3.AX balance_sheet (annual, 2023-03-31) — Common Stock: 109672616.00
CD3.AX cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -40407943.00
CD3.AX balance_sheet (annual, 2023-03-31) — Common Stock Equity: 155217412.00
CD3.AX balance_sheet (annual, 2023-03-31) — Current Deferred Liabilities: 1635389.00
CD3.AX balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 1635389.00
CD3.AX income_statement (annual, 2023-03-31) — Diluted Average Shares: 72028420.00
CD3.AX income_statement (annual, 2023-03-31) — Diluted EPS: 0.41
CD3.AX cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 45108780.00
CD3.AX cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 2215955.00
CD3.AX cash_flow (annual, 2023-03-31) — End Cash Position: 29291029.00
CD3.AX cash_flow (annual, 2023-03-31) — Financing Cash Flow: -40407943.00
CD3.AX cash_flow (annual, 2023-03-31) — Free Cash Flow: -1336307.00
CD3.AX balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 29160.00
CD3.AX cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: -142144.00
CD3.AX income_statement (annual, 2023-03-31) — Interest Income: 197075.00
CD3.AX cash_flow (annual, 2023-03-31) — Investing Cash Flow: 45108780.00
CD3.AX balance_sheet (annual, 2023-03-31) — Investments And Advances: 133124884.00
CD3.AX balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 133124884.00
CD3.AX income_statement (annual, 2023-03-31) — Net Income: 29317390.00
CD3.AX income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 29317390.00
CD3.AX income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 29317390.00
CD3.AX income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 29317390.00
CD3.AX income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 29317390.00
CD3.AX income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 29317390.00
CD3.AX income_statement (annual, 2023-03-31) — Net Interest Income: 197075.00
CD3.AX balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 155217412.00
CD3.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 5399930.00
CD3.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 5399930.00
CD3.AX income_statement (annual, 2023-03-31) — Normalized Income: 29317390.00
CD3.AX income_statement (annual, 2023-03-31) — Operating Revenue: 233026.90
CD3.AX balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 72028420.00
CD3.AX income_statement (annual, 2023-03-31) — Other Non Interest Expense: 433445.00
CD3.AX income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 29944163.00
CD3.AX balance_sheet (annual, 2023-03-31) — Other Payable: 203502.00
CD3.AX balance_sheet (annual, 2023-03-31) — Payables: 204888.00
CD3.AX balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 204888.00
CD3.AX income_statement (annual, 2023-03-31) — Pretax Income: 30122090.00
CD3.AX income_statement (annual, 2023-03-31) — Professional Expense And Contract Services Expense: 1075791.00
CD3.AX balance_sheet (annual, 2023-03-31) — Receivables: 29160.00
CD3.AX balance_sheet (annual, 2023-03-31) — Retained Earnings: 45544796.00
CD3.AX balance_sheet (annual, 2023-03-31) — Share Issued: 72028420.00
CD3.AX balance_sheet (annual, 2023-03-31) — Stockholders Equity: 155217412.00
CD3.AX balance_sheet (annual, 2023-03-31) — Tangible Book Value: 155217412.00
CD3.AX income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
CD3.AX income_statement (annual, 2023-03-31) — Tax Provision: 804700.00
CD3.AX income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.03
CD3.AX balance_sheet (annual, 2023-03-31) — Total Assets: 162457619.00
CD3.AX balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 155217412.00
CD3.AX balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 7240207.00
CD3.AX income_statement (annual, 2024-03-31) — +Total Revenue: 615698.00
CD3.AX balance_sheet (annual, 2024-03-31) — Accounts Payable: 598.00
CD3.AX balance_sheet (annual, 2024-03-31) — Accounts Receivable: 25656.00
CD3.AX income_statement (annual, 2024-03-31) — Basic Average Shares: 72028420.00
CD3.AX income_statement (annual, 2024-03-31) — Basic EPS: 0.03
CD3.AX cash_flow (annual, 2024-03-31) — Beginning Cash Position: 29291029.00
CD3.AX balance_sheet (annual, 2024-03-31) — Capital Stock: 109672616.00
CD3.AX balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 13185011.00
CD3.AX balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 13185011.00
CD3.AX cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -26650516.00
CD3.AX balance_sheet (annual, 2024-03-31) — Cash Financial: 13185011.00
CD3.AX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: -26650516.00
CD3.AX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: 11458749.00
CD3.AX cash_flow (annual, 2024-03-31) — Cash Flowsfromusedin Operating Activities Direct: -1397903.00
CD3.AX cash_flow (annual, 2024-03-31) — Changes In Cash: -16589670.00
CD3.AX cash_flow (annual, 2024-03-31) — Classesof Cash Payments: -1655662.00
CD3.AX cash_flow (annual, 2024-03-31) — Classesof Cash Receiptsfrom Operating Activities: 257759.00
CD3.AX balance_sheet (annual, 2024-03-31) — Common Stock: 109672616.00
CD3.AX cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -26650516.00
CD3.AX balance_sheet (annual, 2024-03-31) — Common Stock Equity: 130811714.00
CD3.AX income_statement (annual, 2024-03-31) — Diluted Average Shares: 72028420.00
CD3.AX income_statement (annual, 2024-03-31) — Diluted EPS: 0.03
CD3.AX cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 11458749.00
CD3.AX cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 483652.00
CD3.AX cash_flow (annual, 2024-03-31) — End Cash Position: 13185011.00
CD3.AX cash_flow (annual, 2024-03-31) — Financing Cash Flow: -26650516.00
CD3.AX cash_flow (annual, 2024-03-31) — Free Cash Flow: -1397903.00
CD3.AX balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 25656.00
CD3.AX cash_flow (annual, 2024-03-31) — Income Tax Paid Supplemental Data: 508477.00
CD3.AX income_statement (annual, 2024-03-31) — Interest Income: 257858.00
CD3.AX cash_flow (annual, 2024-03-31) — Investing Cash Flow: 11458749.00
CD3.AX balance_sheet (annual, 2024-03-31) — Investments And Advances: 120804006.00
CD3.AX balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 120804006.00
CD3.AX income_statement (annual, 2024-03-31) — Net Income: 2244818.00
CD3.AX income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 2244818.00
CD3.AX income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 2244818.00
CD3.AX income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 2244818.00
CD3.AX income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 2244818.00
CD3.AX income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 2244818.00
CD3.AX income_statement (annual, 2024-03-31) — Net Interest Income: 257858.00
CD3.AX balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 130811714.00
CD3.AX balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 4977952.00
CD3.AX balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 4977952.00
CD3.AX income_statement (annual, 2024-03-31) — Normalized Income: 2244818.00
CD3.AX income_statement (annual, 2024-03-31) — Operating Revenue: 615698.00
CD3.AX balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 72028420.00
CD3.AX income_statement (annual, 2024-03-31) — Other Non Interest Expense: 30036.00
CD3.AX income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 2300503.00
CD3.AX balance_sheet (annual, 2024-03-31) — Other Payable: 140288.00
CD3.AX balance_sheet (annual, 2024-03-31) — Payables: 140886.00
CD3.AX balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 140886.00
CD3.AX income_statement (annual, 2024-03-31) — Pretax Income: 1930775.00
CD3.AX income_statement (annual, 2024-03-31) — Professional Expense And Contract Services Expense: 955390.00
CD3.AX balance_sheet (annual, 2024-03-31) — Receivables: 25656.00
CD3.AX balance_sheet (annual, 2024-03-31) — Retained Earnings: 21139098.00
CD3.AX balance_sheet (annual, 2024-03-31) — Share Issued: 72028420.00
CD3.AX balance_sheet (annual, 2024-03-31) — Stockholders Equity: 130811714.00
CD3.AX balance_sheet (annual, 2024-03-31) — Tangible Book Value: 130811714.00
CD3.AX income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
CD3.AX income_statement (annual, 2024-03-31) — Tax Provision: -314043.00
CD3.AX income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
CD3.AX balance_sheet (annual, 2024-03-31) — Total Assets: 135930552.00
CD3.AX balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 130811714.00
CD3.AX balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 5118838.00
CD3.AX income_statement (annual, 2025-03-31) — +Total Revenue: -171161.00
CD3.AX balance_sheet (annual, 2025-03-31) — Accounts Payable: 10989.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 10989.00
CD3.AX balance_sheet (annual, 2025-03-31) — Accounts Receivable: 19666.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 19666.00
CD3.AX income_statement (annual, 2025-03-31) — Basic Average Shares: 72028420.00
CD3.AX income_statement (annual, 2025-03-31) — Basic EPS: 0.26
CD3.AX cash_flow (annual, 2025-03-31) — Beginning Cash Position: 13185011.00
CD3.AX balance_sheet (annual, 2025-03-31) — Capital Stock: 109672616.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 109672616.00
CD3.AX balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 9989349.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 9989349.00
CD3.AX balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 9989349.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 9989349.00
CD3.AX cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -14405684.00
CD3.AX balance_sheet (annual, 2025-03-31) — Cash Financial: 9989349.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Cash Financial: 9989349.00
CD3.AX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: -14405684.00
CD3.AX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: 11944511.00
CD3.AX cash_flow (annual, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: -848219.00
CD3.AX cash_flow (annual, 2025-03-31) — Changes In Cash: -3309392.00
CD3.AX cash_flow (annual, 2025-03-31) — Classesof Cash Payments: -1000913.00
CD3.AX cash_flow (annual, 2025-03-31) — Classesof Cash Receiptsfrom Operating Activities: 152694.00
CD3.AX balance_sheet (annual, 2025-03-31) — Common Stock: 109672616.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Common Stock: 109672616.00
CD3.AX cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -14405684.00
CD3.AX balance_sheet (annual, 2025-03-31) — Common Stock Equity: 134961359.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 134961359.00
CD3.AX balance_sheet (annual, 2025-03-31) — Current Deferred Liabilities: 41443.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 41443.00
CD3.AX balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 41443.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 41443.00
CD3.AX income_statement (annual, 2025-03-31) — Diluted Average Shares: 72028420.00
CD3.AX income_statement (annual, 2025-03-31) — Diluted EPS: 0.26
CD3.AX cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 11944511.00
CD3.AX cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 113730.00
CD3.AX cash_flow (annual, 2025-03-31) — End Cash Position: 9989349.00
CD3.AX cash_flow (annual, 2025-03-31) — Financing Cash Flow: -14405684.00
CD3.AX cash_flow (annual, 2025-03-31) — Free Cash Flow: -848219.00
CD3.AX balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 19666.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 19666.00
CD3.AX cash_flow (annual, 2025-03-31) — Income Tax Paid Supplemental Data: 51805.00
CD3.AX income_statement (annual, 2025-03-31) — Interest Income: 146233.00
CD3.AX cash_flow (annual, 2025-03-31) — Investing Cash Flow: 11944511.00
CD3.AX balance_sheet (annual, 2025-03-31) — Investments And Advances: 129513536.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 129513536.00
CD3.AX balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 129513536.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 129513536.00
CD3.AX income_statement (annual, 2025-03-31) — Net Income: 18555329.00
CD3.AX income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 18555329.00
CD3.AX income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 18555329.00
CD3.AX income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 18555329.00
CD3.AX income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 18555329.00
CD3.AX income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 18555329.00
CD3.AX income_statement (annual, 2025-03-31) — Net Interest Income: 146233.00
CD3.AX balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 134961359.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 134961359.00
CD3.AX balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 4398978.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4398978.00
CD3.AX balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4398978.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4398978.00
CD3.AX income_statement (annual, 2025-03-31) — Normalized Income: 18555329.00
CD3.AX income_statement (annual, 2025-03-31) — Operating Revenue: -171161.00
CD3.AX balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 72028420.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 72028420.00
CD3.AX income_statement (annual, 2025-03-31) — Other Non Interest Expense: 5299.00
CD3.AX income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 17340168.00
CD3.AX balance_sheet (annual, 2025-03-31) — Other Payable: 123620.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Other Payable: 123620.00
CD3.AX balance_sheet (annual, 2025-03-31) — Payables: 134609.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Payables: 134609.00
CD3.AX balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 134609.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 134609.00
CD3.AX income_statement (annual, 2025-03-31) — Pretax Income: 16323231.00
CD3.AX income_statement (annual, 2025-03-31) — Professional Expense And Contract Services Expense: 840477.00
CD3.AX balance_sheet (annual, 2025-03-31) — Receivables: 19666.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Receivables: 19666.00
CD3.AX balance_sheet (annual, 2025-03-31) — Retained Earnings: 25288743.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 25288743.00
CD3.AX balance_sheet (annual, 2025-03-31) — Share Issued: 72028420.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Share Issued: 72028420.00
CD3.AX balance_sheet (annual, 2025-03-31) — Stockholders Equity: 134961359.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 134961359.00
CD3.AX balance_sheet (annual, 2025-03-31) — Tangible Book Value: 134961359.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 134961359.00
CD3.AX income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CD3.AX income_statement (annual, 2025-03-31) — Tax Provision: -2232098.00
CD3.AX income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
CD3.AX balance_sheet (annual, 2025-03-31) — Total Assets: 139536389.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Total Assets: 139536389.00
CD3.AX balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 134961359.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 134961359.00
CD3.AX balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4575030.00
CD3.AX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4575030.00
CD3.AX income_statement (annual, 2026-03-31) — +Total Revenue: -696691.00
CD3.AX balance_sheet (annual, 2026-03-31) — Accounts Payable: 7421.00
CD3.AX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 7421.00
CD3.AX balance_sheet (annual, 2026-03-31) — Accounts Receivable: 13969.00
CD3.AX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 13969.00